Research Applications Lipid Metabolism & Fat Oxidation Methionine, Choline, and Inositol act synergistically as lipotropic agents enhancing the transport and metabolism of fats from the liver
Rat studies on Achilles tendon transection, patellar ligament rupture, and rotator cuff injuries consistently show accelerated healing timelines, improved tensile strength, and superior histological organization in BPC-157-treated groups versus untreated controls
Current guidelines recommend GLP-1s for adults with obesity (BMI at or above 30), or adults with overweight (BMI at or above 27) plus a weight-related comorbidity such as type 2 diabetes, hypertension, fatty liver disease, or sleep apnea, for whom the cardiometabolic benefit of the medication exceeds its risks
It Supports Muscle Preservation During Caloric Deficit GLP-1 medications work primarily by reducing appetite and slowing gastric emptying, which creates a sustained caloric deficit
4 weeks Minimum interval between dose increases 2mg to 12mg Phase 2 dose range (Jastreboff 2023) ~12 weeks Time to reach 12mg on standard protocol 24.2% Weight loss at 12mg, 48 weeks (Phase 2) Investigational Drug Warning Retatrutide (LY3437943) is not FDA-approved as of April 2026
